Fine mapping of QT interval regions in global populations refines previously identified QT interval loci and identifies signals unique to African and Hispanic descent populations by Avery, Christy L. et al.
Fine-Mapping of QT Regions in Global Populations Refines 
Previously Identified QT Loci and Identifies Signals Unique to 
African and Hispanic Descent Populations
Christy L. Avery, PhD, Christina L. Wassel, PhD, Melissa A. Richard, PhD, Heather M. 
Highland, PhD, Stephanie Bien, PhD, Niha Zubair, PhD, Elsayed Z. Soliman, MD, Myriam 
Fornage, PhD, Suzette J. Bielinski, PhD, Ran Tao, PhD, Amanda A. Seyerle, PhD, Sanjiv J. 
Shah, MD, Donald M. Lloyd-Jones, MD, ScM, Steven Buyske, MD, ScM, Jerome I. Rotter, 
MD, Wendy S. Post, MD, MS, Stephen S. Rich, PhD, Lucia A. Hindorff, PhD, Janina M. Jeff, 
PhD, Ralph V. Shohet MD, MD, Nona Sotoodehnia, MD, MPH, Dan Yu Lin, PhD, Eric A. 
Whitsel, MD, MPH, Ulrike Peters, PhD, Christopher A. Haiman, PhD, Dana C. Crawford, 
PhD, Charles Kooperberg, PhD, and Kari E. North, PhD, MS
Departments of Epidemiology (CLA, HMH, AAS, EAW, KEN), Carolina Population Center (CLA), 
Biostatistics (RT, DYL), Medicine (EAW), Carolina Center for Genome Sciences (KEN), University 
of North Carolina at Chapel Hill, Chapel Hill, NC, USA; Department of Pathology and Laboratory 
Medicine, College of Medicine, University of Vermont, Burlington, VT, USA (CLW); Institute of 
Molecular Medicine (MAR, MF) and Human Genetics Center (MAR, MF), School of Public Health, 
University of Texas Health Science Center at Houston, Houston, TX, USA; Division of Public 
Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA (SB, NZ, UP, CK); 
Epidemiological Cardiology Research Center, Department of Epidemiology and Prevention and 
Department of Internal Medicine, Section on Cardiology, Wake Forest School of Medicine, 
Winston Salem, NC, USA (EZS); Division of Epidemiology, Department of Health Sciences 
Research, Mayo Clinic, Rochester, MN, USA (SJB); Departments of Preventive Medicine and 
Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA (SJS, DML-J); 
Department of Statistics & Biostatistics and Department of Genetics, Rutgers University, 
Piscataway, NJ, USA (SB); Institute for Translational Genomics and Population Sciences, Los 
Angeles Biomedical Research Institute and Department of Pediatrics at Harbor-UCLA Medical 
Center, Torrance, CA, USA (JIR); Departments of Medicine and Epidemiology, Johns Hopkins 
University, Baltimore, MD, USA (WSP); Center for Public Health Genomics, University of Virginia, 
Charlottesville, VA, USA (SSR); National Institutes of Health, National Human Genome Research 
Institute, Office of Population Genomics, Bethesda, MD, USA (LAH); Genetics and Genomic 
Sciences, The Charles Bronfman Institute for Personalized Medicine, The Center for Statistical 
Genetics, and The Institute for Genomics and Multiscale Biology, Icahn School of Medicine at 
Mount Sinai, New York, New York (JMJ); Center for Cardiovascular Research, John A. Burns 
Corresponding Author: Christy L. Avery, Department of Epidemiology, University of North Carolina Chapel Hill, 137 E. Franklin St., 
Suite 306, Chapel Hill, NC 27514, (919) 966-4312 (voice), (919) 966-9800 (fax), christy_avery@unc.edu. 
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our 
customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of 
the resulting proof before it is published in its final citable form. Please note that during the production process errors may be 
discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
We have no conflicts to disclose.
HHS Public Access
Author manuscript
Heart Rhythm. Author manuscript; available in PMC 2018 April 01.
Published in final edited form as:













School of Medicine, University of Hawaii, Honolulu, HI, USA (RVS); Cardiovascular Health 
Research Unit, Division of Cardiology, University of Washington, Seattle, WA, USA (NS); 
Department of Preventive Medicine, Keck School of Medicine and Norris Comprehensive Cancer 
Center, University of Southern California, Pasadena, CA, USA (CAH); Department of 
Epidemiology & Biostatistics, Institute for Computational Biology, Case Western Reserve 
University, Cleveland, Ohio, USA (DCC)
Abstract
Background—The electrocardiographically measured QT interval (QT) is heritable and its 
prolongation is an established risk factor for several cardiovascular diseases. Yet, most QT genetic 
studies have been performed in European ancestral populations, possibly reducing their global 
relevance.
Objective—To leverage diversity and improve biologic insight, we fine-mapped 16 of the 35 
previously identified QT loci (46%) in populations of African American (n=12,410) and Hispanic/
Latino (n=14,837) ancestry.
Methods and Results—The 16 fine-mapped QT loci included on the Illumina Metabochip 
represented 21 independent signals, of which 16 (76%) were significantly (P-value≤9.1×10−5) 
associated with QT after inverse-variance weighted transethnic meta-analysis of racial/ethnic-
specific multiple linear regression analyses adjusted for heart rate and clinical covariates. Through 
sequential conditional analysis we also identified three trans-ethnic novel SNPs at ATP1B1, 
SCN5A-SCN10A, and KCNQ1 and three Hispanic/Latino-specific novel SNPs at NOS1AP and 
SCN5A-SCN10A (two novel SNPs) with evidence of associations with QT independent of 
previous identified GWAS lead SNPs. Linkage disequilibrium patterns helped to narrow the region 
likely to contain the functional variants at several loci, including NOS1AP, USP50-TRPM7, and 
PRKCA, although intervals surrounding SLC35F1-PLN and CNOT1 remained broad in size (>100 
kb). Finally, bioinformatics-based functional characterization suggested a regulatory function in 
cardiac tissues for the majority of independent signals that generalized and the novel SNPs.
Conclusion—Our findings suggest that a majority of identified SNPs implicate gene regulatory 
dysfunction in QT prolongation, that the same loci influence variation in QT across global 
populations, and that additional, novel, population-specific QT signals exist.
Keywords
Genetic epidemiology; minority health; QT interval; fine-mapping; electrocardiography
INTRODUCTION
The role of QT interval (QT) prolongation in the etiology of ventricular arrhythmias that 
predispose to sudden cardiac death (SCD), a leading cause of mortality,1 was recognized as 
early as 1957 upon the identification of a congenital long QT syndrome. Sixty years later, 
population-based research has demonstrated the potential for studies of QT prolongation to 
enhance mechanistic understanding of SCD3–5 as well as coronary heart disease6 and 
stroke.7 Drug-induced QT prolongation also has attracted regulatory scrutiny as the most 
common cause of the withdrawal or restricted marketing of pharmaceuticals.4, 5 Yet, 
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identification of populations at increased risk of SCD following innate or acquired QT 
prolongation remains difficult, necessitating a better understanding of underlying molecular 
mechanisms.8
Genome-wide association studies (GWAS) have identified 35 QT loci,9–18 predominantly in 
large (n~100,000) populations of European descent,9–15 providing new insights into 
mechanisms underlying ventricular conduction.19 QT GWAS in Indian Asian,15 East 
Asian,16, 17 and African American populations have been performed, but identified fewer 
loci than GWAS in European descent populations, likely reflecting smaller sample sizes 
(n=2,994–12, lower genotyping array coverage,15,17,18or imputation to suboptimal reference 
panels. The global relevance of previously identified QT loci and whether population-
specific SNP influencing QT exist therefore remain largely unknown. Further, several 
populations not yet included in QT GWAS, including Hispanics/Latinos, trace their recent 
origins to Europe, Africa, and the Americas,20 presenting exceptional yet underutilized 
opportunities for fine-mapping, particularly when combined with data from African 
Americans. Here, we extend our previous QT fine-mapping study of n=8,644 African 
American participants and 11 QT loci densely genotyped on the Illumina Metabochip 
array21 by including n=3,766 additional African American and n=14,837 Hispanic/Latinos 
participants and evaluating four additional loci.
MATERIALS AND METHODS
Study Populations
The Population Architecture Using Genomics and Epidemiology (PAGE) consortium is a 
National Human Genome Research Institute (NHGRI)-funded effort examining the 
epidemiologic architecture of genetic variants associated with human diseases and traits 
across diverse populations. Six PAGE studies,22 in addition to the Multi-Ethnic Study of 
Atherosclerosis, contributed data to this study (Online Material and Methods). For all 
populations, race/ethnicity was defined by self-report; ancestral outliers were identified 
principal components analysis and excluded. All procedures performed in studies of human 
participants were approval by local institutional review boards.
Genotype platforms
The Metabochip is a custom Illumina iSELECT array designed to support large scale follow 
up of cardiovascular and metabolic loci, including QT.23 Sixteen QT loci (46% of QT loci 
identified as of October, 2016) were represented on the Metabochip (Table 1, Online 
Supplement). Index SNPs, i.e. locus-specific SNPs with the lowest P-value reported by 
previous GWAS, that were not directly genotyped on the Metabochip were, when possible, 
represented by SNPs in high linkage disequilibrium (LD; r2 ≥ 0.80) with the index SNP in 
the ancestral population in which the association was first reported.
Statistical Analysis
To interpret fine-mapping results, LD was calculated in 500 Kb sliding windows using 
PLINK24 and African American, Hispanic/Latino, and trans-ethnic (i.e. combined African 
American and Hispanic/Latino) data, the latter in proportion to racial/ethnic-specific (i.e. 
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each race/ethnicity separately) sample sizes. Metabochip LD and allele frequency 
information for a European population was provided for 2,143 Malmö Diet and Cancer 
Study control participants.25
Racial/ethnic-stratified linear regression (ARIC, EAGLE BioVU, CARDIA, CHS, MESA, 
and WHI; implemented in PLINK24) or a weighted version of generalized estimating 
equations (HCHS/SOL; implemented in SUGEN)26 were used to evaluate the association 
between QT and a maximum of 7,239 SNPs (racial/ethnic-specific minor allele frequency 
(MAF) ≥0.01) from 16 previously identified QT loci assuming an additive genetic model 
and including age, sex, study center/region, ancestry principal components, and heart rate as 
covariates. Racial/ethnic-stratified and trans-ethnic estimates were combined via inverse 
variance meta-analysis using METAL.27
Generalization
We first evaluated whether loci identified in European populations generalized to African 
American and Hispanic/Latino populations by identifying all common and low-frequency 
(MAF≥1%) index SNPs and all SNPs correlated with the index SNPs (r2≥0.20) using 
Malmö Diet and Cancer Study LD estimates; these are the only SNPs evaluated for 
generalization. For loci with multiple index SNPs, SNPs with r2 <0.20 were considered 
independent signals. The generalization significance criterion was defined as αa=9.1×10−5, 
calculated using the number of tag SNPs in African Americans (r2≥0.80; determined using 
African American LD patterns) that captured all SNPs that were correlated with the index 
SNPs (r2≥0.20; determined using Malmö Diet and Cancer Study LD patterns). Index SNPs 
rs10919070 (ATP1B1), rs11756438 (SLC35F1-PLN), rs2072413 (KCNH2), rs7122937 
(KCNQ1), rs2074238 (KCNQ1) did not pass quality control and no proxy was available for 
rs2968864 (KCNH2). For KCNJ2, all SNPs correlated with the index SNPs either did not 
pass quality control or had MAF<0.01.
Novel SNP Identification
To identify novel SNPs, we selected all SNPs at the 16 QT loci that were uncorrelated with 
the index SNPs (r2≤0.20 in the Malmö Diet and Cancer Study), which potentially represent 
genetic associations not previously reported for QT. Sequential conditional analyses were 
then performed adjusting for significant lead SNPs, i.e. the most significant trans-ethnic or 
racial/ethnic SNP at each locus, until no significant SNPs remained. If a statistically 
significant SNP was identified, defined as 0.05 divided by the number of SNPs in African 
Americans with MAF ≥ 0.01 that were uncorrelated with the index SNPs (n=6,082; 
αb=8.22×10−6), the SNP was identified as novel and added to the adjustment set.
Bioinformatics Categorization of QT loci
Functional annotation was performed for all significant lead SNPs, novel SNPs, and 
correlated SNP (r2≥0.80; identified in the appropriate 1000 Genomes reference populations) 
in relevant cardiac tissues. Specifically, using HaploRegV2 (http://www.broadinstitute.org/
mammals/haploreg/haploreg.php), all SNPs in each LD block were characterized with 
putative functional roles including: conservation; promoter and/or enhancer epigenetic 
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markers, derived from the Roadmap Epigenomics Project and ENCODE; DNAse 
hypersensitive sites; and transcription factor binding motifs.
RESULTS
Participants were drawn from seven studies (Online Supplement), which contributed 12,410 
African American and 14,837 Hispanic/Latino participants (Table S1). The majority of 
participants were female (71%) and the mean age ranged from 39–73 years. Estimates of 
mean QT and heart rate were generally consistent across studies (weighted mean=408 ms), 
but were expectedly lower in EAGLE BioVu given exclusion criteria (Online Supplement).
We examined a maximum of 7,239 SNPs at 16 previously identified QT loci represented on 
the Metabochip. In African Americans, the number of SNPs at each locus ranged from 
421,195 (mean number of SNPs per locus=451, Table S2). Among Hispanic/Latinos, the 
number of SNPs per locus was slightly lower and ranged from 33–97 (mean number of 
SNPs per locus=361).
Generalization
A total of 39 QT index SNPs across 21 independent signals were identified, with the 
NOS1AP, ATP1B1, SLC35F1-PLN, and KCNH2 loci harboring multiple independent 
signals (Table 1). Sixteen (76%) independent signals generalized to the trans-ethnic 
population, encompassing 12 QT loci (Table 1, Table S3, S4). Among these 16 independent 
signals, six lead SNPs were identical to previously reported index SNPs [rs846111 
(RNF207), rs12143842 (NOS1AP), rs2968863 (KCNH2), rs12296050 (KCNQ1), rs735951 
(LITAF), and rs2074518 (LIG3)], six lead SNPs were equivalent to previously reported 
index SNPs (i.e. P-values within ~1 order of magnitude), and four lead SNPs had P-values at 
least two orders of magnitude farther from the null than index SNP P-values (Table S3). For 
example, the SCN5A-SCN10A index SNPs P-values were approximately five times lower in 
magnitude (index SNP P-value range: 0.0015–0.024, Table S3) than the trans-ethnic lead 
SNP P-value of 3.2×10−8 (Table 1). Effect sizes also were consistently lower among African 
Americans than Hispanic/Latinos.
The trans-ethnic lead SNP was also identical to the racial/ethnic-specific lead SNP for 11 of 
the 16 independent signals in African Americans and 10 of the 16 independent signals in 
Hispanic/Latinos (Table S5) and effect sizes were again consistently of smaller magnitude in 
African Americans. For the remaining independent signals, P-values for the racial/ethnic-
specific lead SNPs were equivalent to (i.e. within approximately one order of magnitude) the 
trans-ethnic lead SNP, with the exception of one lead SNP in African Americans (RNF207) 
and two lead SNPs in Hispanic/Latinos (NOS1AP independent signal 3 and KCNH2 
independent signal 1) (Table S3).
Among the five independent signals that did not generalize to the trans-ethnic population 
(SLC35F1-PLNindependent signal 2, CAV1 ATP2A2, LIG3, and KCNE1), effect estimates 
for all but KCNE1 were directionally consistent with effects estimated in European ancestral 
populations, but of considerably smaller magnitude, particularly among African Americans 
(Table S4). For the KCNE1 independent signal, no SNPs with MAF>1% were identified, 
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although rs1805128, the KCNE1 index SNP, was significant in Hispanic/Latinos 
(MAF=0.0053; P-value = 1.4×10−7) (Table S3).
Finally, varied generalization success was observed for racial/ethnic-specific analyses. For 
example, only five independent signals generalized to African Americans, whereas 15 
independent signals generalized to Hispanic/Latinos. Other notable observations include the 
consistently lower estimated effects in African Americans compared to Hispanic/Latinos 
(Table S3).
Locus Refinement
We then examined the degree to which LD patterns assisted with the narrowing of 
independent signals that generalized (Table S6; Figures 1–4, Figures S1–S8). On average, 
African American LD patterns were associated with the fewest number of SNPs correlated 
with the lead SNP and the smallest interval size. However, trans-ethnic LD patterns 
produced slightly smaller interval sizes when restricted to independent signals that 
generalized to African Americans and Hispanic/Latinos separately.
Novel Signals
We identified three trans-ethnic novel SNPs at ATP1B1, SCN5A-SCN10A, and KCNQ1 and 
three Hispanic/Latino-specific novel SNPs at NOS1AP and SCN5A-SCN10A (two SNPs) 
(Tables 2, 3, Figures 1–4). Notably, the three SCN5A-SCN10A novel SNPs were 
uncorrelated when examining African American (r2<0.038), European (r2<0.052), and 
Hispanic/Latino (r2<0.095) LD patterns. Effect estimates for novel Hispanic/Latino SNPs 
(beta range:−1.17,−2.34) also were almost twice as large as effects estimated in African 
Americans (beta range:−0.62, −1.22, Table 2).
Bioinformatics Characterization
Bioinformatics characterization identified three nonsynonymous coding SNPs, for which in 
silico prediction algorithms indicated that the amino acid changes were tolerated (Tables S7, 
S8). With the exception of four SNPs in Hispanic/Latinos and two SNPs in African 
Americans, all independent signals contained at least one SNP with evidence for a 
regulatory function in one or more relevant tissues.
DISCUSSION
Here we conducted the largest and most racially/ethnically diverse fine-mapping study of 
QT to-date. We demonstrated allelic heterogeneity through the identification of multiple 
independent signals, refined the location of previously known QT loci by reducing the 
number of potential causal variants for future interrogation, and identified racial/ethnic-
specific signals. These efforts enhance our understanding of the genetic architecture of QT 
in previously underrepresented populations.
One notable observation was our success generalizing QT loci trans-ethnically, suggesting 
that previously identified independent signals are relevant across global populations. 
However, we had different degrees of success generalizing QT loci to each population 
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separately. Although we increased our sample size approximately 50%,21 we still only 
generalized a handful (~24%) of independent signals to African Americans, for whom effect 
sizes were consistently of smaller magnitude when compared to Hispanic/Latinos or 
European populations. In contrast, 71% of independent signals successfully generalized to 
Hispanic/Latinos, despite approximately equivalent effective sample sizes between the two 
study populations. These distinctions may reflect greater average European ancestry in 
Hispanic/Latinos compared to African Americans28 and a higher proportion of shared 
functional variants. The LD structure in Hispanic/Latino and European ancestral populations 
also may be more similar to each other than to African populations, thus enabling the 
detection of functional variants. In addition, the Metabochip was developed using an early 
release of the 1000 Genomes Project and therefore incompletely captured African-specific 
variation,23 despite low LD and high genetic heterogeneity that make African populations 
ideal for fine-mapping.29
The need to further expand fine-mapping efforts is underscored by findings for NOS1AP 
independent signal 1 that harbors rs12143842. Rs12143842 is the most commonly reported 
QT index SNP identified to-date and also was identified by our trans-ethnic and racial/
ethnic-specific meta-analyses. Yet, functional studies of NOS1AP identified rs7539120, not 
rs12143842, as the functional variant,19 although rs7539120 was not genotyped on the 
Metabochip. Inconsistencies between prior GWAS and NOS1AP functional studies likely 
reflect both the HapMap2 platform to which the majority of prior GWAS were imputed, 
which did not include rs7539120, and the decreased imputation accuracy for rs7539120 
compared to rs12143842 that lowered estimated effects for rs7539120 in contrast to 
rs12143842. Interestingly, rs12143842 and rs7539120 are weakly correlated in the 1000 
Genomes Americans of African Ancestry in SW USA (ASW) population (r2=0.16), but 
moderately correlated in the European (EUR, r2=0.54) and Admixed American (AMR, 
r2=0.38) populations. These findings suggest that fine-mapping in African American 
populations, enabled by denser genotyping or high quality imputation, may have negated the 
targeted saturation sequencing of NOS1AP in European ancestral populations that was 
required to pinpoint the causal variant.
We also reported varied success in narrowing intervals surrounding previously identified 
GWAS index SNPs. For several loci, including RNF207, NOS1AP, ATP1B1, SCN5A-
SCN10A, and KCNQ1, we identified a limited number of SNPs for future interrogation. 
Indeed, recent functional studies have identified RNF207 as an important regulator of 
cardiac excitation, although few studies have been performed to pinpoint the exact causal 
SNPs. RNF207 also was the only locus for which bioinformatics characterization identified 
a nonsynonymous SNP, rs846111, although in silico prediction suggested that the amino 
acid change was tolerated. Yet, trans-ethnic and racial/ethnic-specific LD patterns did not 
identify any SNPs in high LD with rs846111. Additional work examining a denser panel of 
SNPs at this locus is likely warranted.
Despite success for several independent signals, substantial narrowing of intervals was not 
achieved for other independent signals, including CNOT1 and SLC35F1-PLN independent 
signal 1, possibly reflecting LD block size and the extent of LD differences with the causal 
variant between ancestral populations. Expansion of fine-mapping efforts to include other 
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global populations may offer improved locus refinement. For example, wide variation in the 
number of SNPs correlated with SLC35F1-PLN index SNP rs11153730 in 1000 Genomes 
populations was observed, ranging from 61 in the Han Chinese in Beijing to 134 in the ASW 
population. Future studies should evaluate the extent to which East Asian populations can be 
used to further narrow the SCL35F1-PLN locus.
There are several limitations of the present study. First, although the Metabochip included 
dense genotyping of 16 QT loci, the majority of recently discovered QT loci were excluded. 
Second, it is possible that the causative variants were not included on the Metabochip, 
necessitating future sequencing studies or studies for which high imputation accuracy is 
possible, both of which are outside the scope of the current effort. Finally, the implications 
of conducting a QT GWAS in predominantly female populations shouldering higher burdens 
of QT-prolonging risk factors than the original discovery populations, e.g. obesity and 
diabetes, also deserves examination, including the degree to which variation in known QT 
correlates modify reported genetic associations and underlying pathways.31,32
In conclusion, our findings suggest that the same genes influence variation in QT across 
ancestral populations and that additional, novel and possibly population-specific signals 
exist, which together implicate gene regulatory dysfunction. Additional characterization of 
QT loci through whole-genome sequencing or large-scale genotyping combined with 
imputation panels that capture population genetic content may further illuminate the genetic 
and molecular mechanisms underlying QT.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Racial/ethnic-specific and trans-ethnic regional association plots for NOS1AP independent 
signals 1 (panels A–C), 2 (panels D–F), and 3 (panels G–I). Population-specific log10P-
values (left y axis) are plotted against the SNP genomic position (NCBI build 36, x axis); the 
estimated recombination rate from the 1000 Genomes project is shown in blue on the right y 
axis. Lead SNPs are denoted with a purple diamond. SNPs are colored to reflect population-
specific r2 with the lead SNP. Novel SNPs are denoted by vertical lines and stars.
Avery et al. Page 11














Racial/ethnic-specific and trans-ethnic regional association plots for ATP1B1 independent 
signals 1 (panels A–C) and 2 (panels D–F). Population-specific log10P-values (left y axis) 
are plotted against the SNP genomic position (NCBI build 36, x axis); the estimated 
recombination rate from the 1000 Genomes project is shown in blue on the right y axis. 
Lead SNPs are denoted with a purple diamond. SNPs are colored to reflect population-
specific r2 with the lead SNP. Novel SNPs are denoted by vertical lines and stars.
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Racial/ethnic-specific and trans-ethnic regional association plots for SCN5A/SCN10A. 
Population-specific log10P-values (left y axis) are plotted against the SNP genomic position 
(NCBI build 36, x axis); the estimated recombination rate from the 1000 Genomes project is 
shown in blue on the right y axis. Lead SNPs are denoted with a purple diamond. SNPs are 
colored to reflect population-specific r2 with the lead SNP. Novel SNPs are denoted by 
vertical lines and stars.
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Racial/ethnic-specific and trans-ethnic regional association plots for KCNQ1. Population-
specific log10P-values (left y axis) are plotted against the SNP genomic position (NCBI 
build 36, x axis); the estimated recombination rate from the 1000 Genomes project is shown 
in blue on the right y axis. Lead SNPs are denoted with a purple diamond. SNPs are colored 
to reflect population-specific r2 with the lead SNP. Novel SNPs are denoted by vertical lines 
and stars.
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